SASKATOON, Sept. 23, 2013 /CNW/ - For Canadians suffering from chronic
and terminal illnesses including severe pain, chronic inflammation due
to arthritis or the nausea associated with chemotherapy, medical
marijuana has become a well-recognized option for patients and doctors
to try when conventional medicine just isn't enough.
Today, Health Canada licensed the first two companies under the new Marihuana for Medical Purposes Regulations - Prairie Plant Systems Inc. and CanniMed Ltd.
"As the sole supplier to Health Canada for the last 13 years, patients
and physicians have come to trust the safety and efficacy of the
Prairie Plant Systems pharmaceutical-grade cannabis," said Brent Zettl,
CEO, Prairie Plant Systems. "We are very pleased to have been awarded
the first two licenses under the new medical marijuana regulations."
In addition to receiving a license for Prairie Plant Systems, today
marks the launch of CanniMed Ltd., a subsidiary to Prairie Plant
Systems, which will be the distribution and support hub for patients
and physicians, as well as the brand name of the three
pharmaceutical-grade cannabis products that will be made available as
soon as physically possible - CanniMed® 17.1, CanniMed® 12.0 and
About Medical Marijuana
Marijuana is the common name for the cannabis plant. The active
ingredients, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD),
bind to chemical receptors in the human body, which appears to enhance
some responses like appetite, and inhibiting others, such as pain and
nausea. These effects are what make it potentially useful in treating
certain medical conditions.
Scientific studies have begun to demonstrate some of the beneficial
effects of cannabis treatment on chronic disease symptom management.
Much more clinical research is required to fully understand the modes
of action of the various cannabinoids and their effects on the human
Medical marijuana has been used for many conditions, including, but not
Alleviating pain due to advanced cancer or rheumatoid arthritis
Alleviating neuropathic pain common with patients with spinal cord
injuries and multiple sclerosis
Relieving nausea and reducing the incidence of vomiting
Increasing food consumption and caloric intake with HIV/AIDS patients
About Prairie Plant Systems & CanniMed
Prairie Plant Systems has been the sole supplier of medical marijuana to
Health Canada for the last 13 years and our pharmaceutical-grade
cannabis is produced with the same standards and procedures as required
of all pharmaceutical companies in Canada.
CanniMed Ltd. (www.cannimed.ca) is our distribution and support network for both patients and
physicians and Prairie Plant Systems will continue to focus on research
and development, conducting clinical trials and quality control.
"Patient safety is our primary focus, which means that patients and
their healthcare professionals can trust our consistent and reliable
product every time," added Mr. Zettl. "We have a quality control
process with 281 points of control, ensuring that there is no
variability, giving patient's confidence in dose consistency."
We are committed to standardizing care by taking a leadership role in
closing the gap between the anecdotal benefit of medical marijuana and
evidenced-based scientific research. Our goal is to provide improved
access for Canadians who rely on medical marijuana through scientific
collaborations with external partners including academic institutions
and healthcare professionals.
To date, the pharmaceutical grade cannabis produced by Prairie Plant
Systems has been used in published clinical trial results demonstrating
the efficacy of smoked cannabis for chronic pain.i Additional clinical trials are currently underway using different
medical marijuana varieties, in controlled medical conditions.
i Ware, M. A., Wang, T., Shapiro, S., Robinson, A. and others. (2010) Smoked Cannabis for Chronic Pain: a Randomized Controlled Trial. Canadian Medical Association Journal (CMAJ). 182:E694-E701.
Image with caption: "CanniMed Product Photo (CNW Group/Prairie Plant Systems Inc.)". Image available at: http://photos.newswire.ca/images/download/20130923_C9378_PHOTO_EN_31135.jpg
Image with caption: "Prairie Plant Systems Logo (CNW Group/Prairie Plant Systems Inc.)". Image available at: http://photos.newswire.ca/images/download/20130923_C9378_PHOTO_EN_31137.jpg
Image with caption: "CanniMed logo (CNW Group/Prairie Plant Systems Inc.)". Image available at: http://photos.newswire.ca/images/download/20130923_C9378_PHOTO_EN_31136.jpg
SOURCE: Prairie Plant Systems Inc.
For further information:
Marketing & Communications Coordinator
Prairie Plant Systems Inc.
Dara Willis Communications